CRBP
Corbus Pharmaceuticals Holding
6.10$
-3.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 86.0% | 83.3% | 96.8% | 97.6% | 98.0% | 98.1% | 98.2% | 98.2% | 98.2% | 99.3% | 99.4% | 96.7% | |
| 31.0% | 48.5% | 11.2% | 15.8% | 11.8% | 11.0% | 13.5% | 16.0% | 24.6% | 16.9% | 18.0% | 18.4% | |
| 79.2% | 73.9% | 95.5% | 96.9% | 97.1% | 95.6% | 94.9% | 93.2% | 94.9% | 97.5% | 95.9% | 92.9% | |
| – | – | – | – | – | – | – | 1.2% | 1.4% | 0.9% | – | – | |
| 99.1% | 124.4% | 22.9% | 17.4% | 8.3% | 8.6% | 9.2% | 11.3% | 15.9% | 12.3% | 12.6% | 19.5% | |
| 86.9% | 112.8% | 20.6% | 15.8% | 7.1% | 7.6% | 8.3% | 10.7% | 15.6% | 12.3% | 12.6% | 16.9% | |
| 53.0% | 62.4% | 11.5% | 8.1% | 1.0% | 1.0% | 1.2% | 1.4% | 1.6% | 1.0% | 0.8% | 0.8% | |
| 13.0% | 11.2% | 1.7% | 0.8% | 1.8% | 3.1% | 2.9% | 3.2% | 2.5% | 1.3% | 0.3% | 4.1% | |
| 0.9% | -24.4% | 77.1% | 82.6% | 91.7% | 91.4% | 90.8% | 88.7% | 84.1% | 87.7% | 87.4% | 80.5% | |
| -1,181.4% | -1,544.6% | -352.8% | -298.4% | -284.7% | -305.9% | -352.9% | -408.9% | -488.4% | -330.2% | -400.3% | -483.1% | |
| 12.2% | 15.6% | 2.2% | 1.9% | 7.3% | 7.8% | 8.7% | 9.8% | 11.2% | 7.9% | 12.9% | 15.3% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.